Director Kevin P. Clark filed a Form 4 with the SEC on September 10, 2026, disclosing the sale of 122,722 ordinary shares of Versigent PLC (NASDAQ:VGNT) across six transactions on September 8 and 9, 2026, pursuant to a Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: Kevin P. Clark, identified as a Director of Versigent PLC.
  • Total shares sold: 122,722 ordinary shares disposed of across six separate transactions on September 8 and 9, 2026.
  • Price range: Weighted average sale prices per transaction ranged from $45.49 to $49.67; individual transaction prices ranged as low as $44.99 and as high as $50.12, according to the filing.
  • Remaining ownership: Following all reported transactions, Clark directly beneficially owned 124,849 ordinary shares.
  • Trading plan: All sales were effected pursuant to a Rule 10b5-1 trading plan adopted June 3, 2026, through the Kevin P. Clark 2002 Revocable Trust.
  • Transaction code: All six transactions were coded "S" (sale) in the filing.

Kevin P. Clark's Share Sales at Versigent PLC: Transaction Details

According to the Form 4 filed September 10, 2026, Clark conducted three sales on September 8, 2026. The first involved 38,271 ordinary shares at a weighted average price of $47.85, with individual sale prices ranging from $47.30 to $48.29. The second covered 9,034 shares at a weighted average of $48.50, with prices ranging from $48.30 to $49.28. The third involved 1,287 shares at a weighted average of $49.67, with prices ranging from $49.40 to $50.12. After these three transactions, Clark's directly held position stood at 198,979 ordinary shares, the filing shows.

On September 9, 2026, Clark reported three additional sales. The first covered 57,508 shares at a weighted average of $45.49, with prices ranging from $44.99 to $45.98. The second involved 16,517 shares at a weighted average of $46.27, with prices ranging from $45.99 to $46.93. The third disposed of 105 shares, all sold at $47.08. Following these September 9 transactions, Clark's directly held beneficial ownership totaled 124,849 ordinary shares, according to the filing.

The filing notes that all sales were made through the Kevin P. Clark 2002 Revocable Trust under a Rule 10b5-1 trading plan adopted on June 3, 2026. The filing further discloses that Clark "undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price" for each transaction reported with a weighted average price. The form was signed by Janis Acosta as attorney-in-fact for Kevin P. Clark on September 10, 2026. No derivative securities transactions were reported.

What Was Disclosed

The filing disclosed six open-market sales of Versigent PLC ordinary shares by Director Kevin P. Clark on September 8 and 9, 2026, totaling 122,722 shares, all executed under a pre-established Rule 10b5-1 plan, leaving Clark with 124,849 directly held shares.